Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 16

1.

Heterogeneous local dynamics revealed by classification analysis of spatially disaggregated time series data.

Perkins TA, Rodriguez-Barraquer I, Manore C, Siraj AS, España G, Barker CM, Johansson MA, Reiner RC Jr.

Epidemics. 2019 Dec;29:100357. doi: 10.1016/j.epidem.2019.100357. Epub 2019 Jul 22.

2.

Pre-vaccination screening strategies for the use of the CYD-TDV dengue vaccine: A meeting report.

Wilder-Smith A, Smith PG, Luo R, Kelly-Cirino C, Curry D, Larson H, Durbin A, Chu M, Tharmaphornpilas P, Ng LC, Sartori AMC, Luna EJA, Gubler DJ, España G, Yoon IK, Flasche S.

Vaccine. 2019 Aug 23;37(36):5137-5146. doi: 10.1016/j.vaccine.2019.07.016. Epub 2019 Jul 31.

PMID:
31377079
3.

Model-based assessment of public health impact and cost-effectiveness of dengue vaccination following screening for prior exposure.

España G, Yao Y, Anderson KB, Fitzpatrick MC, Smith DL, Morrison AC, Wilder-Smith A, Scott TW, Perkins TA.

PLoS Negl Trop Dis. 2019 Jul 1;13(7):e0007482. doi: 10.1371/journal.pntd.0007482. eCollection 2019 Jul.

4.

An agent-based model of dengue virus transmission shows how uncertainty about breakthrough infections influences vaccination impact projections.

Perkins TA, Reiner RC Jr, España G, Ten Bosch QA, Verma A, Liebman KA, Paz-Soldan VA, Elder JP, Morrison AC, Stoddard ST, Kitron U, Vazquez-Prokopec GM, Scott TW, Smith DL.

PLoS Comput Biol. 2019 Mar 20;15(3):e1006710. doi: 10.1371/journal.pcbi.1006710. eCollection 2019 Mar.

5.

Biased efficacy estimates in phase-III dengue vaccine trials due to heterogeneous exposure and differential detectability of primary infections across trial arms.

España G, Hogea C, Guignard A, Ten Bosch QA, Morrison AC, Smith DL, Scott TW, Schmidt A, Perkins TA.

PLoS One. 2019 Jan 25;14(1):e0210041. doi: 10.1371/journal.pone.0210041. eCollection 2019.

6.

Local and regional dynamics of chikungunya virus transmission in Colombia: the role of mismatched spatial heterogeneity.

Moore SM, Ten Bosch QA, Siraj AS, Soda KJ, España G, Campo A, Gómez S, Salas D, Raybaud B, Wenger E, Welkhoff P, Perkins TA.

BMC Med. 2018 Aug 30;16(1):152. doi: 10.1186/s12916-018-1127-2.

7.

Exploring scenarios of chikungunya mitigation with a data-driven agent-based model of the 2014-2016 outbreak in Colombia.

España G, Grefenstette J, Perkins A, Torres C, Campo Carey A, Diaz H, de la Hoz F, Burke DS, van Panhuis WG.

Sci Rep. 2018 Aug 15;8(1):12201. doi: 10.1038/s41598-018-30647-8.

8.

Spatiotemporal incidence of Zika and associated environmental drivers for the 2015-2016 epidemic in Colombia.

Siraj AS, Rodriguez-Barraquer I, Barker CM, Tejedor-Garavito N, Harding D, Lorton C, Lukacevic D, Oates G, Espana G, Kraemer MUG, Manore C, Johansson MA, Tatem AJ, Reiner RC, Perkins TA.

Sci Data. 2018 Apr 24;5:180073. doi: 10.1038/sdata.2018.73.

9.

Pokémon Go and Exposure to Mosquito-Borne Diseases: How Not to Catch 'Em All.

Oidtman RJ, Christofferson RC, Ten Bosch QA, Espana G, Kraemer MU, Tatem A, Barker CM, Perkins TA.

PLoS Curr. 2016 Nov 15;8. pii: ecurrents.outbreaks.2d885b05c7e06a9f72e4656d56b043cd. doi: 10.1371/currents.outbreaks.2d885b05c7e06a9f72e4656d56b043cd.

10.

The Long-Term Safety, Public Health Impact, and Cost-Effectiveness of Routine Vaccination with a Recombinant, Live-Attenuated Dengue Vaccine (Dengvaxia): A Model Comparison Study.

Flasche S, Jit M, Rodríguez-Barraquer I, Coudeville L, Recker M, Koelle K, Milne G, Hladish TJ, Perkins TA, Cummings DA, Dorigatti I, Laydon DJ, España G, Kelso J, Longini I, Lourenco J, Pearson CA, Reiner RC, Mier-Y-Terán-Romero L, Vannice K, Ferguson N.

PLoS Med. 2016 Nov 29;13(11):e1002181. doi: 10.1371/journal.pmed.1002181. eCollection 2016 Nov.

11.

Effect of nitroglycerine in popliteal preparations from patients with peripheral occlusive arteriopathy precontracted with KCl or 5-hydroxytryptamine.

Ortega A, Avellanal M, España G, Flores A, Aleixandre A.

Clin Exp Pharmacol Physiol. 2003 Aug;30(8):528-31.

PMID:
12890172
12.

Morphometric and immunocytochemical study of the fetal, infant, and adult human vas deferens.

Regadera J, España G, Roias MA, Recio JA, Nistal M, Suárez-Quian CA.

J Androl. 1997 Nov-Dec;18(6):623-36.

13.

[Anatomy and development of the testicular venous system].

Redondo E, Regadera J, Nistal M, Rey A, España G, Regadera-Sejas FJ, Codesal J.

Arch Esp Urol. 1988 Apr;41(3):171-8. Review. Spanish. No abstract available.

PMID:
3041919
14.

[Development of the arteries of the leg and foot in human fetuses: angiographic study].

España G, Sánchez-Coll S, Regadera J, Redondo E, Rodríguez JI, Jiménez-Cossío JA.

Angiologia. 1987 Jul-Aug;39(4):178-85. Spanish. No abstract available.

PMID:
3631641
15.

[Development of the femoro-popliteal sector in human fetuses].

España G, Regadera J, Sánchez-Coll S, Rodríguez-González JI, Sáez JL, Hernández A, Alamo O, Magallón P, Jiménez-Cossío J.

Angiologia. 1986 May-Jun;38(3):171-7. Spanish. No abstract available.

PMID:
3740539
16.

An improved benzene extracted complement fixing antigen for certain neurotropic viruses.

ESPANA G, HAMMON WM.

Proc Soc Exp Biol Med. 1947 Oct;66(1):101. No abstract available.

PMID:
20270687

Supplemental Content

Loading ...
Support Center